These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8750563)

  • 1. Sulfonylurea receptors and mechanism of sulfonylurea action.
    Panten U; Schwanstecher M; Schwanstecher C
    Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic and extrapancreatic sulfonylurea receptors.
    Panten U; Schwanstecher M; Schwanstecher C
    Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-cell response to oral hypoglycemic agents.
    Cook DL
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S81-9. PubMed ID: 8529522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the glycaemic effects of sulfonylureas.
    Ashcroft FM
    Horm Metab Res; 1996 Sep; 28(9):456-63. PubMed ID: 8911983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
    Aguilar-Bryan L; Nichols CG; Wechsler SW; Clement JP; Boyd AE; González G; Herrera-Sosa H; Nguy K; Bryan J; Nelson DA
    Science; 1995 Apr; 268(5209):423-6. PubMed ID: 7716547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.
    Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S
    Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The sulfonylurea receptor].
    Inagaki N; Gonoi T; Seino S
    Seikagaku; 1997 Sep; 69(9):1067-80. PubMed ID: 9364874
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor.
    Dunne MJ; Kane C; Shepherd RM; Sanchez JA; James RF; Johnson PR; Aynsley-Green A; Lu S; Clement JP; Lindley KJ; Seino S; Aguilar-Bryan L
    N Engl J Med; 1997 Mar; 336(10):703-6. PubMed ID: 9041101
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.
    Bryan J; Crane A; Vila-Carriles WH; Babenko AP; Aguilar-Bryan L
    Curr Pharm Des; 2005; 11(21):2699-716. PubMed ID: 16101450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta-cell K(ATP) channel.
    Ashcroft SJ
    J Membr Biol; 2000 Aug; 176(3):187-206. PubMed ID: 10931971
    [No Abstract]   [Full Text] [Related]  

  • 13. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
    Inagaki N; Gonoi T; Clement JP; Namba N; Inazawa J; Gonzalez G; Aguilar-Bryan L; Seino S; Bryan J
    Science; 1995 Nov; 270(5239):1166-70. PubMed ID: 7502040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.
    Nagashima K; Takahashi A; Ikeda H; Hamasaki A; Kuwamura N; Yamada Y; Seino Y
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S75-8. PubMed ID: 15563985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular basis of oral hypoglycemic sulfonylurea action].
    Owecki M; Horst-Sikorska W; Sowiński J
    Pol Merkur Lekarski; 2003 Nov; 15(89):445-8. PubMed ID: 14969140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea receptors, ion channels, and fruit flies.
    Boyd AE
    Diabetes; 1988 Jul; 37(7):847-50. PubMed ID: 2454858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sulfonylurea drugs for type 2 diabetes].
    Toyota T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():339-45. PubMed ID: 12387015
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.
    Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ
    Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.